However, as we could show expression of KRT13 in the basal cells of benign glands, and since the loss of basal cells is one hallmark of prostate adenocarcinoma [48], lower expression levels in urine could also be explained by increased tumoral occupation of the gland. This evidence concerns the gene KRT13 and prostate adenocarcinoma.